PEPGEN
PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.
PEPGEN
Industry:
Biotechnology Clinical Trials Medical
Founded:
2018-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pepgen.com
Total Employee:
11+
Status:
Active
Contact:
+44 1865 618 820
Email Addresses:
[email protected]
Total Funding:
159.58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Sitelinks Search Box Euro Organization Schema IPv6
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Home Biosciences
Home Biosciences is a European venture builder dedicated to biotech.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Onego Bio
Onego Bio is a smart protein is a piece of cake.
Upacjenta
Upacjenta is to popularize preventive laboratory tests among Polish women and Poles.
Venn Life Sciences
Contract research providing clinical trial services from pre-clinical to Phase III
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Laurion Capital Management
Laurion Capital Management investment in Venture Round - Pepgen
CureDuchenne Ventures
CureDuchenne Ventures investment in Venture Round - Pepgen
Viking Global Investors
Viking Global Investors investment in Venture Round - Pepgen
Gray’s Creek Capital Partners
Gray’s Creek Capital Partners investment in Venture Round - Pepgen
Adage Capital Management
Adage Capital Management investment in Venture Round - Pepgen
Samsara BioCapital
Samsara BioCapital investment in Venture Round - Pepgen
Qatar Investment Authority
Qatar Investment Authority investment in Venture Round - Pepgen
RA Capital Management
RA Capital Management investment in Venture Round - Pepgen
Tudor Investments
Tudor Investments investment in Venture Round - Pepgen
Deerfield
Deerfield investment in Venture Round - Pepgen
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | PepGen Bolsters R&D Team with Appointment of Jaya Goyal, Ph.D., as Executive Vice President of Research and Preclinical Development |
Official Site Inspections
http://www.pepgen.com Semrush global rank: 4.28 M Semrush visits lastest month: 2.69 K
- Host name: 2.124.145.34.bc.googleusercontent.com
- IP address: 34.145.124.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pepgen"
About – PepGen
Prior to PepGen, Mary Beth spent 15 years at Alnylam Pharmaceuticals in roles of increasing responsibility, most recently serving as Senior Vice President, Deputy General Counsel, and …See details»
Pepgen - Crunchbase Company Profile & Funding
PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their …See details»
Pepgen - Crunchbase Company Profile & Funding
Organization. Pepgen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. ... Pepgen is a privately-held biopharmaceutical company that develops and commercializes novel products …See details»
PepGen
PepGenSee details»
PepGen Inc. - AnnualReports.com
PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced …See details»
PepGen Inc. (PEPG) Company Profile & Facts - Yahoo Finance
PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts. Corporate Governance PepGen Inc.’s ISS Governance QualityScore as of November 1, 2024 is 6.See details»
PepGen - LinkedIn
PepGen | 9,908 followers on LinkedIn. Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. | Driven by our proprietary Enhanced Delivery Oligonucleotide ...See details»
PepGen Company Profile 2024: Stock Performance & Earnings
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and …See details»
PepGen Announces New Additions to Leadership Team and Board …
Aug 31, 2021 PepGen is rapidly advancing lead programs in Duchenne muscular dystrophy and myotonic dystrophy type 1 to the clinic and growing its team in Boston, MA. BOSTON, Aug. …See details»
PepGen Inc. (PEPG) Company Profile & Overview - Stock Analysis
May 6, 2022 PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and …See details»
Pepgen Corporation - VentureRadar
"PepGen is revolutionizing the treatment of neuromuscular diseases through its proprietary Enhanced Delivery Oligonucleotide (EDO) platform. The company focuses on developing a …See details»
PepGen Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic …See details»
PepGen Reports Third Quarter 2024 Financial Results and Recent …
Sep 30, 2024 In August, PepGen appointed Paul Streck, MD, MBA, as Executive Vice President and Head of the Company’s R&D organization. He brings more than 20 years of leadership …See details»
PepGen to Present Late-Breaking Data from Novel Enhanced …
Mar 15, 2021 PepGen, Inc. is a biotechnology company focused on transforming the care of patients with neuromuscular diseases through the peptide-mediated delivery of nucleic acid …See details»
Mission, Vision & Core Values of Pepgen – CBM
Nov 6, 2024 [cbm_blg_rlnkng]At Pepgen, our mission is simple yet powerful: to revolutionize the field of regenerative medicine by developing cutting-edge peptide therapies. Our vision is to …See details»
PepGen Announces Closing of $112.5 Million Crossover
Aug 5, 2021 The company is headquartered in Boston, Mass. For more information, visit www.pepgen.com or follow PepGen on Twitter and LinkedIn. Media Contact. Gwendolyn …See details»
PepGen Reports First Quarter 2024 Financial Results and Recent ...
May 14, 2024 PepGen continues to advance PGN-EDO53 into investigational new drug (IND) and clinical trial application (CTA) enabling nonclinical studies. Other Corporate Updates In …See details»
PEPG - PepGen Inc. | Overview | OTC Markets
3 days ago PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical DevelopmentBUSINESS WIRE | 11/21/2024 …See details»
PepGen Inc. (PEPG) Stock Price, Quote & News - Stock Analysis
Nov 22, 2024 PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular …See details»